Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01999517 · ClinicalTrials.gov registry record · Phase 4
Contrast Nephropathy and Nitrates
A Phase 4 study of Contrast Induced Nephropathy, sponsored by Mt. Sinai Medical Center, Miami.
- Completed
- Registry status
- Phase 4
- Development phase
- 122
- Enrollment target
- 1
- Study location
NCT01999517 is a Phase 4 study of Contrast Induced Nephropathy that has completed, run by Mt. Sinai Medical Center, Miami. The registered enrollment target is 122 participants, below the 245-participant average among 3 other Contrast Induced Nephropathy trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01999517, a Phase 4 study of Contrast Induced Nephropathy, has completed, sponsored by Mt. Sinai Medical Center, Miami.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 122 participants
- Enrollment target
- 1
- Study location
Study Summary
Contrast-induced nephropathy (CIN) is a complication of percutaneous coronary angiography that occurs in about 10 to 20% of patients exposed to contrast media. Iodinated contrast is used during coronary angiography to see the coronary arteries. It has been shown that exposure to this agent may cause kidney injury. CIN usually goes away on its own but in some high risk patients it progresses into renal failure. This research study offers a new possible option to prevent CIN. We propose that if intravenous nitroglycerin is given before the procedure it may lower the chances of developing contrast-induced nephropathy.
Conditions Studied
Interventions
- DRUG Intravenous Nitroglycerin
- DRUG IV Fluids
Study Locations (1)
Florida
- Mount Sinai Medical Center - Miami Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2013-06 |
| Est. Completion | 2018-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01999517
The ClinicalTrials.gov registry entry for NCT01999517 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 245-participant average among 3 other Contrast Induced Nephropathy trials with a reported enrollment target (50% lower). The listed sponsor is Mt. Sinai Medical Center, Miami, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Contrast Induced Nephropathy appearing as the primary indexed condition, and to 2 interventions - of which Intravenous Nitroglycerin is the first listed.
NCT01999517 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT01999517 about?
NCT01999517 is a clinical study titled "Contrast Nephropathy and Nitrates". Contrast-induced nephropathy (CIN) is a complication of percutaneous coronary angiography that occurs in about 10 to 20% of patients exposed to contrast media. Iodinated contrast is used during coronary angiography to see the coronary arteries. It has been shown that exposure to this agent may cause...
What is the current status of trial NCT01999517?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 122 participants. The study started on 2013-06. Estimated completion is 2018-06.
What conditions does trial NCT01999517 study?
This clinical trial studies the following conditions: Contrast Induced Nephropathy.
What interventions are being tested in trial NCT01999517?
The interventions under investigation include: Intravenous Nitroglycerin (DRUG), IV Fluids (DRUG).
Who is sponsoring clinical trial NCT01999517?
This trial is sponsored by Mt. Sinai Medical Center, Miami, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01999517 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contrast Induced Nephropathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.